(R)-3-Amino-4-(2-fluoro-phenyl)-1-piperazin-1-yl-butan-1-one

ID: ALA184624

Chembl Id: CHEMBL184624

PubChem CID: 9835053

Max Phase: Preclinical

Molecular Formula: C14H20FN3O

Molecular Weight: 265.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@@H](CC(=O)N1CCNCC1)Cc1ccccc1F

Standard InChI:  InChI=1S/C14H20FN3O/c15-13-4-2-1-3-11(13)9-12(16)10-14(19)18-7-5-17-6-8-18/h1-4,12,17H,5-10,16H2/t12-/m1/s1

Standard InChI Key:  ZYVMQOXKKAGGNG-GFCCVEGCSA-N

Associated Targets(Human)

DPP4 Tclin Dipeptidyl peptidase IV (7109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DPP7 Tchem Dipeptidyl peptidase II (2000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
XPNPEP1 Tchem Xaa-Pro aminopeptidase 1 (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PEPD Tchem Xaa-Pro dipeptidase (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 265.33Molecular Weight (Monoisotopic): 265.1590AlogP: 0.52#Rotatable Bonds: 4
Polar Surface Area: 58.36Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.86CX LogP: 0.41CX LogD: -1.57
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.83Np Likeness Score: -1.20

References

1. Brockunier LL, He J, Colwell LF, Habulihaz B, He H, Leiting B, Lyons KA, Marsilio F, Patel RA, Teffera Y, Wu JK, Thornberry NA, Weber AE, Parmee ER..  (2004)  Substituted piperazines as novel dipeptidyl peptidase IV inhibitors.,  14  (18): [PMID:15324904] [10.1016/j.bmcl.2004.06.065]
2. Kim D, Kowalchick JE, Brockunier LL, Parmee ER, Eiermann GJ, Fisher MH, He H, Leiting B, Lyons K, Scapin G, Patel SB, Petrov A, Pryor KD, Roy RS, Wu JK, Zhang X, Wyvratt MJ, Zhang BB, Zhu L, Thornberry NA, Weber AE..  (2008)  Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines.,  51  (3): [PMID:18201067] [10.1021/jm070330v]
3. Kumar S, Mittal A, Mittal A..  (2021)  A review upon medicinal perspective and designing rationale of DPP-4 inhibitors.,  46  [PMID:34428715] [10.1016/j.bmc.2021.116354]

Source